ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Labeled Nucleotides Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-29A4173
Home | Market Reports | Science| Biological Sciences
Global Labeled Nucleotides Market Insights and Forecast to 2028
BUY CHAPTERS

Global Labeled Nucleotides Market Research Report 2025

Code: QYRE-Auto-29A4173
Report
September 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Jena Bioscience
Yumpu
CJ Cheiljedang Corporation
Star Lake Bioscience
ThermoFisher Scientific
Meihua Group
F.Hoffmann-La Roche
Biorigin
DSM Nutritional Products
Promega Corporation
Affymetrix Inc
Agilent Technologies
Lallemand
Nanjing BioTogether

Labeled Nucleotides Market Size

The global market for Labeled Nucleotides was valued at US$ 2303 million in the year 2024 and is projected to reach a revised size of US$ 3769 million by 2031, growing at a CAGR of 7.4% during the forecast period.

Labeled Nucleotides Market

Labeled Nucleotides Market

Labeled nucleotides are modified forms of nucleotides that have a specific chemical or radioactive label attached to them. These labels allow researchers to track, visualize, and detect specific nucleic acids in various molecular biology applications. Labeled nucleotides are commonly used in techniques such as DNA sequencing, PCR (polymerase chain reaction), in situ hybridization, DNA labeling, and nucleic acid microarray analysis.
Labeled nucleotides can be labeled with different types of labels, including fluorescent dyes, radioactive isotopes, or biotin. Fluorescently labeled nucleotides are widely used for fluorescence in situ hybridization (FISH), where they are incorporated into DNA or RNA probes to detect specific sequences in cells or tissues. These probes can be visualized under fluorescence microscopy, allowing for the visualization and localization of specific genetic sequences.
Radioactively labeled nucleotides, such as [32P]-labeled or [35S]-labeled nucleotides, are commonly used in techniques like DNA sequencing or autoradiography. Radioactive labels emit radiation that can be detected using specialized equipment or X-ray films, enabling the determination of nucleotide sequences or the detection of radiolabeled targets in biological samples.
Biotin-labeled nucleotides are frequently used in techniques like DNA labeling or nucleic acid microarray analysis. Biotin is a small molecule that can bind specifically to avidin or streptavidin, allowing for the indirect visualization or detection of the labeled nucleotide through the use of fluorescently or enzymatically labeled avidin/streptavidin conjugates.
The use of labeled nucleotides in molecular biology provides researchers with powerful tools for studying nucleic acids, gene expression, genetic variation, and various other molecular processes. The choice of label depends on the specific application, desired sensitivity, and detection method. Labeled nucleotides enable visualization, quantification, and analysis of nucleic acids, leading to a deeper understanding of genetic information and its role in biological processes.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Labeled Nucleotides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Labeled Nucleotides.
The Labeled Nucleotides market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Labeled Nucleotides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Labeled Nucleotides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Labeled Nucleotides Market Report

Report Metric Details
Report Name Labeled Nucleotides Market
Accounted market size in year US$ 2303 million
Forecasted market size in 2031 US$ 3769 million
CAGR 7.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • TaqMan Allelic Discrimination
  • Gene Chips & Microarrays
  • SNP by Pyrosequencing
Segment by Application
  • Hospital Laboratories
  • Reference Laboratories
  • Academic Research Laboratories
  • Other Laboratories
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Jena Bioscience, Yumpu, CJ CheilJedang Corporation, Star Lake Bioscience, ThermoFisher Scientific, Meihua Group, F. Hoffmann-La Roche, Biorigin, DSM Nutritional Products, Promega Corporation, Affymetrix, Agilent Technologies, Lallemand, Nanjing BioTogether
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Labeled Nucleotides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Labeled Nucleotides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Labeled Nucleotides Market growing?

Ans: The Labeled Nucleotides Market witnessing a CAGR of 7.4% during the forecast period 2025-2031.

What is the Labeled Nucleotides Market size in 2031?

Ans: The Labeled Nucleotides Market size in 2031 will be US$ 3769 million.

Who are the main players in the Labeled Nucleotides Market report?

Ans: The main players in the Labeled Nucleotides Market are Jena Bioscience, Yumpu, CJ CheilJedang Corporation, Star Lake Bioscience, ThermoFisher Scientific, Meihua Group, F. Hoffmann-La Roche, Biorigin, DSM Nutritional Products, Promega Corporation, Affymetrix, Agilent Technologies, Lallemand, Nanjing BioTogether

What are the Application segmentation covered in the Labeled Nucleotides Market report?

Ans: The Applications covered in the Labeled Nucleotides Market report are Hospital Laboratories, Reference Laboratories, Academic Research Laboratories, Other Laboratories

What are the Type segmentation covered in the Labeled Nucleotides Market report?

Ans: The Types covered in the Labeled Nucleotides Market report are TaqMan Allelic Discrimination, Gene Chips & Microarrays, SNP by Pyrosequencing

1 Labeled Nucleotides Market Overview
1.1 Product Definition
1.2 Labeled Nucleotides by Type
1.2.1 Global Labeled Nucleotides Market Value Comparison by Type (2024 VS 2031)
1.2.2 TaqMan Allelic Discrimination
1.2.3 Gene Chips & Microarrays
1.2.4 SNP by Pyrosequencing
1.3 Labeled Nucleotides by Application
1.3.1 Global Labeled Nucleotides Market Value by Application (2024 VS 2031)
1.3.2 Hospital Laboratories
1.3.3 Reference Laboratories
1.3.4 Academic Research Laboratories
1.3.5 Other Laboratories
1.4 Global Labeled Nucleotides Market Size Estimates and Forecasts
1.4.1 Global Labeled Nucleotides Revenue 2020-2031
1.4.2 Global Labeled Nucleotides Sales 2020-2031
1.4.3 Global Labeled Nucleotides Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Labeled Nucleotides Market Competition by Manufacturers
2.1 Global Labeled Nucleotides Sales Market Share by Manufacturers (2020-2025)
2.2 Global Labeled Nucleotides Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Labeled Nucleotides Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Labeled Nucleotides, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Labeled Nucleotides, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Labeled Nucleotides, Product Type & Application
2.7 Global Key Manufacturers of Labeled Nucleotides, Date of Enter into This Industry
2.8 Global Labeled Nucleotides Market Competitive Situation and Trends
2.8.1 Global Labeled Nucleotides Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Labeled Nucleotides Players Market Share by Revenue
2.8.3 Global Labeled Nucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Labeled Nucleotides Market Scenario by Region
3.1 Global Labeled Nucleotides Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Labeled Nucleotides Sales by Region: 2020-2031
3.2.1 Global Labeled Nucleotides Sales by Region: 2020-2025
3.2.2 Global Labeled Nucleotides Sales by Region: 2026-2031
3.3 Global Labeled Nucleotides Revenue by Region: 2020-2031
3.3.1 Global Labeled Nucleotides Revenue by Region: 2020-2025
3.3.2 Global Labeled Nucleotides Revenue by Region: 2026-2031
3.4 North America Labeled Nucleotides Market Facts & Figures by Country
3.4.1 North America Labeled Nucleotides Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Labeled Nucleotides Sales by Country (2020-2031)
3.4.3 North America Labeled Nucleotides Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Labeled Nucleotides Market Facts & Figures by Country
3.5.1 Europe Labeled Nucleotides Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Labeled Nucleotides Sales by Country (2020-2031)
3.5.3 Europe Labeled Nucleotides Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Labeled Nucleotides Market Facts & Figures by Region
3.6.1 Asia Pacific Labeled Nucleotides Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Labeled Nucleotides Sales by Region (2020-2031)
3.6.3 Asia Pacific Labeled Nucleotides Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Labeled Nucleotides Market Facts & Figures by Country
3.7.1 Latin America Labeled Nucleotides Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Labeled Nucleotides Sales by Country (2020-2031)
3.7.3 Latin America Labeled Nucleotides Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Labeled Nucleotides Market Facts & Figures by Country
3.8.1 Middle East and Africa Labeled Nucleotides Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Labeled Nucleotides Sales by Country (2020-2031)
3.8.3 Middle East and Africa Labeled Nucleotides Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Labeled Nucleotides Sales by Type (2020-2031)
4.1.1 Global Labeled Nucleotides Sales by Type (2020-2025)
4.1.2 Global Labeled Nucleotides Sales by Type (2026-2031)
4.1.3 Global Labeled Nucleotides Sales Market Share by Type (2020-2031)
4.2 Global Labeled Nucleotides Revenue by Type (2020-2031)
4.2.1 Global Labeled Nucleotides Revenue by Type (2020-2025)
4.2.2 Global Labeled Nucleotides Revenue by Type (2026-2031)
4.2.3 Global Labeled Nucleotides Revenue Market Share by Type (2020-2031)
4.3 Global Labeled Nucleotides Price by Type (2020-2031)
5 Segment by Application
5.1 Global Labeled Nucleotides Sales by Application (2020-2031)
5.1.1 Global Labeled Nucleotides Sales by Application (2020-2025)
5.1.2 Global Labeled Nucleotides Sales by Application (2026-2031)
5.1.3 Global Labeled Nucleotides Sales Market Share by Application (2020-2031)
5.2 Global Labeled Nucleotides Revenue by Application (2020-2031)
5.2.1 Global Labeled Nucleotides Revenue by Application (2020-2025)
5.2.2 Global Labeled Nucleotides Revenue by Application (2026-2031)
5.2.3 Global Labeled Nucleotides Revenue Market Share by Application (2020-2031)
5.3 Global Labeled Nucleotides Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Jena Bioscience
6.1.1 Jena Bioscience Company Information
6.1.2 Jena Bioscience Description and Business Overview
6.1.3 Jena Bioscience Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Jena Bioscience Labeled Nucleotides Product Portfolio
6.1.5 Jena Bioscience Recent Developments/Updates
6.2 Yumpu
6.2.1 Yumpu Company Information
6.2.2 Yumpu Description and Business Overview
6.2.3 Yumpu Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Yumpu Labeled Nucleotides Product Portfolio
6.2.5 Yumpu Recent Developments/Updates
6.3 CJ CheilJedang Corporation
6.3.1 CJ CheilJedang Corporation Company Information
6.3.2 CJ CheilJedang Corporation Description and Business Overview
6.3.3 CJ CheilJedang Corporation Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CJ CheilJedang Corporation Labeled Nucleotides Product Portfolio
6.3.5 CJ CheilJedang Corporation Recent Developments/Updates
6.4 Star Lake Bioscience
6.4.1 Star Lake Bioscience Company Information
6.4.2 Star Lake Bioscience Description and Business Overview
6.4.3 Star Lake Bioscience Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Star Lake Bioscience Labeled Nucleotides Product Portfolio
6.4.5 Star Lake Bioscience Recent Developments/Updates
6.5 ThermoFisher Scientific
6.5.1 ThermoFisher Scientific Company Information
6.5.2 ThermoFisher Scientific Description and Business Overview
6.5.3 ThermoFisher Scientific Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.5.4 ThermoFisher Scientific Labeled Nucleotides Product Portfolio
6.5.5 ThermoFisher Scientific Recent Developments/Updates
6.6 Meihua Group
6.6.1 Meihua Group Company Information
6.6.2 Meihua Group Description and Business Overview
6.6.3 Meihua Group Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Meihua Group Labeled Nucleotides Product Portfolio
6.6.5 Meihua Group Recent Developments/Updates
6.7 F. Hoffmann-La Roche
6.7.1 F. Hoffmann-La Roche Company Information
6.7.2 F. Hoffmann-La Roche Description and Business Overview
6.7.3 F. Hoffmann-La Roche Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.7.4 F. Hoffmann-La Roche Labeled Nucleotides Product Portfolio
6.7.5 F. Hoffmann-La Roche Recent Developments/Updates
6.8 Biorigin
6.8.1 Biorigin Company Information
6.8.2 Biorigin Description and Business Overview
6.8.3 Biorigin Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Biorigin Labeled Nucleotides Product Portfolio
6.8.5 Biorigin Recent Developments/Updates
6.9 DSM Nutritional Products
6.9.1 DSM Nutritional Products Company Information
6.9.2 DSM Nutritional Products Description and Business Overview
6.9.3 DSM Nutritional Products Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.9.4 DSM Nutritional Products Labeled Nucleotides Product Portfolio
6.9.5 DSM Nutritional Products Recent Developments/Updates
6.10 Promega Corporation
6.10.1 Promega Corporation Company Information
6.10.2 Promega Corporation Description and Business Overview
6.10.3 Promega Corporation Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Promega Corporation Labeled Nucleotides Product Portfolio
6.10.5 Promega Corporation Recent Developments/Updates
6.11 Affymetrix
6.11.1 Affymetrix Company Information
6.11.2 Affymetrix Description and Business Overview
6.11.3 Affymetrix Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Affymetrix Labeled Nucleotides Product Portfolio
6.11.5 Affymetrix Recent Developments/Updates
6.12 Agilent Technologies
6.12.1 Agilent Technologies Company Information
6.12.2 Agilent Technologies Description and Business Overview
6.12.3 Agilent Technologies Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Agilent Technologies Labeled Nucleotides Product Portfolio
6.12.5 Agilent Technologies Recent Developments/Updates
6.13 Lallemand
6.13.1 Lallemand Company Information
6.13.2 Lallemand Description and Business Overview
6.13.3 Lallemand Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Lallemand Labeled Nucleotides Product Portfolio
6.13.5 Lallemand Recent Developments/Updates
6.14 Nanjing BioTogether
6.14.1 Nanjing BioTogether Company Information
6.14.2 Nanjing BioTogether Description and Business Overview
6.14.3 Nanjing BioTogether Labeled Nucleotides Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Nanjing BioTogether Labeled Nucleotides Product Portfolio
6.14.5 Nanjing BioTogether Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Labeled Nucleotides Industry Chain Analysis
7.2 Labeled Nucleotides Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Labeled Nucleotides Production Mode & Process Analysis
7.4 Labeled Nucleotides Sales and Marketing
7.4.1 Labeled Nucleotides Sales Channels
7.4.2 Labeled Nucleotides Distributors
7.5 Labeled Nucleotides Customer Analysis
8 Labeled Nucleotides Market Dynamics
8.1 Labeled Nucleotides Industry Trends
8.2 Labeled Nucleotides Market Drivers
8.3 Labeled Nucleotides Market Challenges
8.4 Labeled Nucleotides Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Jena Bioscience
Yumpu
CJ Cheiljedang Corporation
Star Lake Bioscience
ThermoFisher Scientific
Meihua Group
F.Hoffmann-La Roche
Biorigin
DSM Nutritional Products
Promega Corporation
Affymetrix Inc
Agilent Technologies
Lallemand
Nanjing BioTogether
List of Tables
 Table 1. Global Labeled Nucleotides Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Labeled Nucleotides Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Labeled Nucleotides Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Labeled Nucleotides Sales (K MT) of Key Manufacturers (2020-2025)
 Table 5. Global Labeled Nucleotides Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Labeled Nucleotides Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Labeled Nucleotides Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Labeled Nucleotides Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Labeled Nucleotides, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Labeled Nucleotides, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Labeled Nucleotides, Product Type & Application
 Table 12. Global Key Manufacturers of Labeled Nucleotides, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Labeled Nucleotides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Labeled Nucleotides as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Labeled Nucleotides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Labeled Nucleotides Sales by Region (2020-2025) & (K MT)
 Table 18. Global Labeled Nucleotides Sales Market Share by Region (2020-2025)
 Table 19. Global Labeled Nucleotides Sales by Region (2026-2031) & (K MT)
 Table 20. Global Labeled Nucleotides Sales Market Share by Region (2026-2031)
 Table 21. Global Labeled Nucleotides Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Labeled Nucleotides Revenue Market Share by Region (2020-2025)
 Table 23. Global Labeled Nucleotides Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Labeled Nucleotides Revenue Market Share by Region (2026-2031)
 Table 25. North America Labeled Nucleotides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Labeled Nucleotides Sales by Country (2020-2025) & (K MT)
 Table 27. North America Labeled Nucleotides Sales by Country (2026-2031) & (K MT)
 Table 28. North America Labeled Nucleotides Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Labeled Nucleotides Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Labeled Nucleotides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Labeled Nucleotides Sales by Country (2020-2025) & (K MT)
 Table 32. Europe Labeled Nucleotides Sales by Country (2026-2031) & (K MT)
 Table 33. Europe Labeled Nucleotides Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Labeled Nucleotides Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Labeled Nucleotides Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Labeled Nucleotides Sales by Region (2020-2025) & (K MT)
 Table 37. Asia Pacific Labeled Nucleotides Sales by Region (2026-2031) & (K MT)
 Table 38. Asia Pacific Labeled Nucleotides Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Labeled Nucleotides Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Labeled Nucleotides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Labeled Nucleotides Sales by Country (2020-2025) & (K MT)
 Table 42. Latin America Labeled Nucleotides Sales by Country (2026-2031) & (K MT)
 Table 43. Latin America Labeled Nucleotides Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Labeled Nucleotides Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Labeled Nucleotides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Labeled Nucleotides Sales by Country (2020-2025) & (K MT)
 Table 47. Middle East and Africa Labeled Nucleotides Sales by Country (2026-2031) & (K MT)
 Table 48. Middle East and Africa Labeled Nucleotides Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Labeled Nucleotides Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Labeled Nucleotides Sales (K MT) by Type (2020-2025)
 Table 51. Global Labeled Nucleotides Sales (K MT) by Type (2026-2031)
 Table 52. Global Labeled Nucleotides Sales Market Share by Type (2020-2025)
 Table 53. Global Labeled Nucleotides Sales Market Share by Type (2026-2031)
 Table 54. Global Labeled Nucleotides Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Labeled Nucleotides Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Labeled Nucleotides Revenue Market Share by Type (2020-2025)
 Table 57. Global Labeled Nucleotides Revenue Market Share by Type (2026-2031)
 Table 58. Global Labeled Nucleotides Price (USD/MT) by Type (2020-2025)
 Table 59. Global Labeled Nucleotides Price (USD/MT) by Type (2026-2031)
 Table 60. Global Labeled Nucleotides Sales (K MT) by Application (2020-2025)
 Table 61. Global Labeled Nucleotides Sales (K MT) by Application (2026-2031)
 Table 62. Global Labeled Nucleotides Sales Market Share by Application (2020-2025)
 Table 63. Global Labeled Nucleotides Sales Market Share by Application (2026-2031)
 Table 64. Global Labeled Nucleotides Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Labeled Nucleotides Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Labeled Nucleotides Revenue Market Share by Application (2020-2025)
 Table 67. Global Labeled Nucleotides Revenue Market Share by Application (2026-2031)
 Table 68. Global Labeled Nucleotides Price (USD/MT) by Application (2020-2025)
 Table 69. Global Labeled Nucleotides Price (USD/MT) by Application (2026-2031)
 Table 70. Jena Bioscience Company Information
 Table 71. Jena Bioscience Description and Business Overview
 Table 72. Jena Bioscience Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. Jena Bioscience Labeled Nucleotides Product
 Table 74. Jena Bioscience Recent Developments/Updates
 Table 75. Yumpu Company Information
 Table 76. Yumpu Description and Business Overview
 Table 77. Yumpu Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Yumpu Labeled Nucleotides Product
 Table 79. Yumpu Recent Developments/Updates
 Table 80. CJ CheilJedang Corporation Company Information
 Table 81. CJ CheilJedang Corporation Description and Business Overview
 Table 82. CJ CheilJedang Corporation Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. CJ CheilJedang Corporation Labeled Nucleotides Product
 Table 84. CJ CheilJedang Corporation Recent Developments/Updates
 Table 85. Star Lake Bioscience Company Information
 Table 86. Star Lake Bioscience Description and Business Overview
 Table 87. Star Lake Bioscience Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Star Lake Bioscience Labeled Nucleotides Product
 Table 89. Star Lake Bioscience Recent Developments/Updates
 Table 90. ThermoFisher Scientific Company Information
 Table 91. ThermoFisher Scientific Description and Business Overview
 Table 92. ThermoFisher Scientific Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. ThermoFisher Scientific Labeled Nucleotides Product
 Table 94. ThermoFisher Scientific Recent Developments/Updates
 Table 95. Meihua Group Company Information
 Table 96. Meihua Group Description and Business Overview
 Table 97. Meihua Group Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. Meihua Group Labeled Nucleotides Product
 Table 99. Meihua Group Recent Developments/Updates
 Table 100. F. Hoffmann-La Roche Company Information
 Table 101. F. Hoffmann-La Roche Description and Business Overview
 Table 102. F. Hoffmann-La Roche Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 103. F. Hoffmann-La Roche Labeled Nucleotides Product
 Table 104. F. Hoffmann-La Roche Recent Developments/Updates
 Table 105. Biorigin Company Information
 Table 106. Biorigin Description and Business Overview
 Table 107. Biorigin Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 108. Biorigin Labeled Nucleotides Product
 Table 109. Biorigin Recent Developments/Updates
 Table 110. DSM Nutritional Products Company Information
 Table 111. DSM Nutritional Products Description and Business Overview
 Table 112. DSM Nutritional Products Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 113. DSM Nutritional Products Labeled Nucleotides Product
 Table 114. DSM Nutritional Products Recent Developments/Updates
 Table 115. Promega Corporation Company Information
 Table 116. Promega Corporation Description and Business Overview
 Table 117. Promega Corporation Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 118. Promega Corporation Labeled Nucleotides Product
 Table 119. Promega Corporation Recent Developments/Updates
 Table 120. Affymetrix Company Information
 Table 121. Affymetrix Description and Business Overview
 Table 122. Affymetrix Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 123. Affymetrix Labeled Nucleotides Product
 Table 124. Affymetrix Recent Developments/Updates
 Table 125. Agilent Technologies Company Information
 Table 126. Agilent Technologies Description and Business Overview
 Table 127. Agilent Technologies Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 128. Agilent Technologies Labeled Nucleotides Product
 Table 129. Agilent Technologies Recent Developments/Updates
 Table 130. Lallemand Company Information
 Table 131. Lallemand Description and Business Overview
 Table 132. Lallemand Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 133. Lallemand Labeled Nucleotides Product
 Table 134. Lallemand Recent Developments/Updates
 Table 135. Nanjing BioTogether Company Information
 Table 136. Nanjing BioTogether Description and Business Overview
 Table 137. Nanjing BioTogether Labeled Nucleotides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 138. Nanjing BioTogether Labeled Nucleotides Product
 Table 139. Nanjing BioTogether Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Labeled Nucleotides Distributors List
 Table 143. Labeled Nucleotides Customers List
 Table 144. Labeled Nucleotides Market Trends
 Table 145. Labeled Nucleotides Market Drivers
 Table 146. Labeled Nucleotides Market Challenges
 Table 147. Labeled Nucleotides Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Labeled Nucleotides
 Figure 2. Global Labeled Nucleotides Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Labeled Nucleotides Market Share by Type: 2024 & 2031
 Figure 4. TaqMan Allelic Discrimination Product Picture
 Figure 5. Gene Chips & Microarrays Product Picture
 Figure 6. SNP by Pyrosequencing Product Picture
 Figure 7. Global Labeled Nucleotides Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Labeled Nucleotides Market Share by Application: 2024 & 2031
 Figure 9. Hospital Laboratories
 Figure 10. Reference Laboratories
 Figure 11. Academic Research Laboratories
 Figure 12. Other Laboratories
 Figure 13. Global Labeled Nucleotides Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Labeled Nucleotides Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Labeled Nucleotides Sales (2020-2031) & (K MT)
 Figure 16. Global Labeled Nucleotides Average Price (USD/MT) & (2020-2031)
 Figure 17. Labeled Nucleotides Report Years Considered
 Figure 18. Labeled Nucleotides Sales Share by Manufacturers in 2024
 Figure 19. Global Labeled Nucleotides Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Labeled Nucleotides Players: Market Share by Revenue in Labeled Nucleotides in 2024
 Figure 21. Labeled Nucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Labeled Nucleotides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Labeled Nucleotides Sales Market Share by Country (2020-2031)
 Figure 24. North America Labeled Nucleotides Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Labeled Nucleotides Sales Market Share by Country (2020-2031)
 Figure 28. Europe Labeled Nucleotides Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Labeled Nucleotides Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Labeled Nucleotides Revenue Market Share by Region (2020-2031)
 Figure 36. China Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Labeled Nucleotides Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Labeled Nucleotides Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Labeled Nucleotides Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Labeled Nucleotides Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Labeled Nucleotides Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Labeled Nucleotides by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Labeled Nucleotides by Type (2020-2031)
 Figure 57. Global Labeled Nucleotides Price (USD/MT) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Labeled Nucleotides by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Labeled Nucleotides by Application (2020-2031)
 Figure 60. Global Labeled Nucleotides Price (USD/MT) by Application (2020-2031)
 Figure 61. Labeled Nucleotides Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions